S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Southwest Oncology Group
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01674140
First received: August 24, 2012
Last updated: January 4, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2030
  Estimated Primary Completion Date: December 2022 (Final data collection date for primary outcome measure)